This report provides a worldwide overview of the clinical chemistry and immunodiagnostics markets, including estimates of the number of laboratories performing assays, as well as test volume and sales forecasts for reagents and instruments by country.
The report presents strategic profiles of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 50 pages and 4 tables
SIMILAR MARKET STUDIES
Europe Flow Cytometry Market 20172020 France Germany Italy Spain UKOpportunities for Instrument and Reagent Suppliers Market Segment Forecasts and Shares Competitive Strategies Emerging Technologies Instrumentation Review
This unique report contains 270 pages, 75 tables and provides information not available from any other published source, including test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of leading instrument and reagents suppliers.This 5-country report will help current suppliers ...
December 2016 | $0 | View Details >>
Summary This comprehensive report from VPGMarketResearch.com contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years. The report explores market and technological trends; provides reagent, instrument and test volume for 40 coagulation procedures; compares features ...
October 2016 | $0 | View Details >>
About Rapid Diagnostics Rapid diagnostic tests are diagnostic assays designed for low-resource settings that provide faster results. These can be carried out either at a patient's bedside or in a clinical setting. These devices are simple to operate and read, have a low cost, and are specific, sensitive, and stable at ...
April 1900 | $2500 | View Details >>
1. INTRODUCTION The government encourages and supports stem cells R&D, cord blood banks had become the most matured segment in the stem cells medicine industry. With government’s supports, Chinese stem cells medicine industry chain which includes, upper-stream technics—cells collection and storage, middle-stream—R&D of drugs, downstream—stem cells treatments, was developed fast. Over ...
May 2015 | $3500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research